A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661.
| Image |  |
|---|---|
| Description | scientific article published on December 2002 |
| Author/s |
author: Michael A Caligiuri Mark J Ratain |
| Publication date | December 1, 2002 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |